(PharmaNewsWire.Com, February 21, 2019 ) According to Fact.MR, the global epistaxis market is expected to represent a value of nearly US$ 13 Mn by the end of 2026.
Conditions that predispose a person to nosebleeds include dry and less humid weather conditions and increasing prevalence of hypertension. According to World Health Organization (WHO), over 12% of the deaths caused globally are due to hypertension. Incidence of nosebleeds continue to increase with the increasing cases of hypertension. Moreover, prevalence of hypertension in pregnant women leads to increasing blood flow towards the mucous membrane. Such factors continue to rev up demand for the epistaxis products in the global market.
Competition Tracking
Leading market players operating on the global epistaxis market include Bristol-Myers Squibb Company, Ciron Drugs & Pharmaceuticals Pvt. Ltd., Pfizer Inc., Medline Industries, Inc., Smith & Nephew, GlaxoSmithKline PLC and Ferring B.V.
Extreme Weather Conditions to Impact Global Market Growth
Epistaxis continues to remain a common health problem observed among the adults and children. Impact of extreme weather conditions can lead to crusting of the mucous secretion processes, which can result into cracks in the nose lining. Extreme dryness and heat in the air can result in dry nasal membrane and eliminates the amount of moisture required to be maintained in the nose. Frequent changes in the environmental conditions such as less humid weather and extremely cold winters lead to increasing instances of dry nasal membrane. Dry nasal membrane leads to increasing occurrences of nosebleeds during the hot, cold and dry weather. Increasing incidences of dry nasal membrane and abnormal nosebleeds is expected to boost demand for epistaxis products during the forecast period.
Innovative Surgeries to Underscore Lucrative Growth Opportunities
Manufacturers are focusing on developing epistaxis products that offer improved performance and result. Incorporation of innovation in the epistaxis products has led to more effective and advanced treatment procedures for epistaxis. Innovative treatment procedures include various surgical and non-surgical interventional procedure. Innovative treatment for nasal packing, embolization and warm water irrigation are a few non-interventional surgeries.
Endoscopic litigation of sphenopaletine artery, maxillary, artery litigation and nasal cauterization are the innovative treatments that include surgical intervention. Adoption of innovative surgeries are significantly changing the trends in the global epistaxis market. Moreover, manufacturers are increasingly focusing on developing epistaxis products for the treatment of patients with special medical conditions such as asthma, pregnancy, diabetes and cancer. These factors are expected to contribute towards growth of the global epistaxis market during the forecast period.
Anterior Indication to Represent a Leading Segment
With the growing incidences of nose cauterization among the children and adults has led to surge in demand for cauterization agents in the global market. On the basis of product type, the cauterization agents segment is expected to represent the highest revenue growth, accounting for a value of over US$ 30 Mn by the end of 2026. On the other hand, the antibiotic ointment product type segment is expected to register a significant CAGR during the forecast period.
Based on distribution channel, the retail pharmacies segment is expected to generate significant revenues, accounting for a value of nearly US$ 20 Mn by the end of 2017. However, the specialty clinics distribution channel segment is expected to register a robust CAGR through 2026.
By indication, the anterior segment is expected to represent a robust revenue growth, recording a value of nearly US$ 80 Mn by the end of 2026. In contrary, the posterior indication segment is expected to register a healthy CAGR throughout the forecast period.
Chapter 2 Global Epistaxis Market - Executive Summary
Chapter 3 Global Epistaxis Market Overview 3.1 Introduction 3.1.1 Global Epistaxis Market Taxonomy 3.1.2 Global Epistaxis Market Definition 3.2 Global Epistaxis Market Size (US$ Mn) and Forecast, 2012-2026 3.2.1 Global Epistaxis Market Y-o-Y Growth 3.3 Global Epistaxis Market Dynamics 3.4 Supply Chain 3.5 Cost Structure 3.6 Epistaxis Epidemiology 3.7 Key Regulations 3.8 Patent Analysis 3.9 PESTL Analysis 3.10 Product Lifecycle 3.11 Pricing Analysis 3.12 Service Provider List 3.13 Key Participants Market Presence (Intensity Map) By Region
Chapter 4 Global Epistaxis Market Analysis and Forecast 2012-2026 4.1 Global Epistaxis Market Size and Forecast by Product, 2012-2026 4.1.1 Vasoconstrictors Market Size and Forecast, 2012-2026 4.1.1.1 Revenue (US$ Mn) Comparison, By Region 4.1.1.2 Market Share Comparison, By Region 4.1.1.3 Y-o-Y growth Comparison, By Region 4.1.2 Anesthetics Market Size and Forecast, 2012-2026 4.1.2.1 Revenue (US$ Mn) Comparison, By Region 4.1.2.2 Market Share Comparison, By Region 4.1.2.3 Y-o-Y growth Comparison, By Region 4.1.3 Antibiotic Ointments Market Size and Forecast, 2012-2026 4.1.3.1 Revenue (US$ Mn) Comparison, By Region 4.1.3.2 Market Share Comparison, By Region 4.1.3.3 Y-o-Y growth Comparison, By Region 4.1.4 Cauterizing Agents Market Size and Forecast, 2012-2026 4.1.4.1 Revenue (US$ Mn) Comparison, By Region 4.1.4.2 Market Share Comparison, By Region 4.1.4.3 Y-o-Y growth Comparison, By Region 4.2 Global Epistaxis Market Size and Forecast by Distribution Channel, 2012-2026 4.2.1 Hospitals Market Size and Forecast, 2012-2026 4.2.1.1 Revenue (US$ Mn) Comparison, By Region 4.2.1.2 Market Share Comparison, By Region 4.2.1.3 Y-o-Y growth Comparison, By Region 4.2.2 Specialty Clinics Market Size and Forecast, 2012-2026 4.2.2.1 Revenue (US$ Mn) Comparison, By Region 4.2.2.2 Market Share Comparison, By Region 4.2.2.3 Y-o-Y growth Comparison, By Region 4.2.3 Retail Pharmacies Market Size and Forecast, 2012-2026 4.2.3.1 Revenue (US$ Mn) Comparison, By Region 4.2.3.2 Market Share Comparison, By Region 4.2.3.3 Y-o-Y growth Comparison, By Region 4.2.4 Other Distribution Channels Market Size and Forecast, 2012-2026 4.2.4.1 Revenue (US$ Mn) Comparison, By Region 4.2.4.2 Market Share Comparison, By Region 4.2.4.3 Y-o-Y growth Comparison, By Region 4.3 Global Epistaxis Market Size and Forecast by Indication, 2012-2026 4.3.1 Posterior Epistaxis Market Size and Forecast, 2012-2026 4.3.1.1 Revenue (US$ Mn) Comparison, By Region 4.3.1.2 Market Share Comparison, By Region 4.3.1.3 Y-o-Y growth Comparison, By Region 4.3.2 Anterior Epistaxis Market Size and Forecast, 2012-2026 4.3.2.1 Revenue (US$ Mn) Comparison, By Region 4.3.2.2 Market Share Comparison, By Region 4.3.2.3 Y-o-Y growth Comparison, By Region
Chapter 5 North America Epistaxis Market Size and Forecast, 2012-2026 5.1 Region Outlook 5.1.1 Political Outlook 5.1.2 Economic Outlook 5.1.3 Business Environment Outlook 5.1.4 North America Healthcare Sector Outlook 5.1.5 Epistaxis Market: North America Region Analysis 5.2 Revenue (US$ Mn) Comparison, By Country 5.3 Revenue (US$ Mn) Comparison, By Product 5.4 Revenue (US$ Mn) Comparison, By Distribution Channel 5.5 Revenue (US$ Mn) Comparison, By Indication
And Continue...
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
Contact Us Rohit Bhisey Fact.MR 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Email: sales@factmr.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
